Equities

Encision Inc

ECIA:PKC

Encision Inc

Actions
  • Price (USD)0.3672
  • Today's Change0.00 / 0.00%
  • Shares traded1.40k
  • 1 Year change-5.85%
  • Beta0.4663
Data delayed at least 15 minutes, as of Apr 29 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Encision Inc. is a medical device company. The Company designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include product and service. Product designs, develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause complications and even death. Its shielded and monitored instruments enable surgeons to perform electrosurgical procedures. It has developed and launched AEM Surgical Instruments and Monitors for laparoscopic surgical procedures. It is also engaged in various manufacturing and assembly activities at its leased facility in Boulder, Colorado.

  • Revenue in USD (TTM)6.87m
  • Net income in USD-448.00k
  • Incorporated1991
  • Employees31.00
  • Location
    Encision Inc6797 Winchester CircleBOULDER 80301United StatesUSA
  • Phone+1 (303) 444-2600
  • Fax+1 (303) 444-2693
  • Websitehttps://www.encision.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tenon Medical Inc2.93m-15.58m3.17m21.00--2.84--1.08-10.28-10.281.620.29920.33593.487.85139,428.60-178.74---264.89--42.38---532.14--1.06--0.6012--323.73--17.63------
Sharps Technology Inc0.00-9.84m3.61m3.00--0.4432-----0.7645-0.76450.000.51950.00-------83.30---109.78----------0.8474--0.00-------112.12------
Aethlon Medical, Inc.574.25k-12.26m3.64m15.00--0.4742--6.34-5.03-5.030.23622.930.0369----38,283.33-78.62-75.30-92.02-84.98-----2,133.17-1,783.78----0.00--95.2130.86-15.55--106.99--
Bioelectronics Corp1.61m-289.82k3.71m9.00------2.30-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
ReShape Lifesciences Inc8.68m-11.39m3.97m31.00--0.596--0.4576-3.77-3.771.460.28410.7960.85154.52279,935.50-104.44-136.06-215.93-194.3263.9356.30-131.22-408.361.74--0.00---22.79-0.947475.36---49.29--
Innovative Eyewear Inc1.15m-6.66m4.02m11.00--0.5345--3.49-0.6442-0.64420.10980.43030.21134.0511.33104,770.90-122.17---137.62---10.35---578.18--8.14-2,255.110.00--74.67---17.28------
Catheter Precision Inc442.00k-71.37m4.24m14.00--0.1857--9.60-25.32-25.320.08063.020.01861.366.4531,571.43-296.70---376.14--93.21---15,966.52--1.67--0.0086--3,057.14---165.67------
Acutus Medical Inc7.16m-11.92m4.30m233.00------0.6003-0.4097-0.4170.2467-0.03080.07651.170.441730,746.78-12.72-46.76-16.05-56.88-43.79-89.12-166.40-773.492.22-6.781.03--136.3627.03-141.35---35.99--
Encision Inc6.87m-448.00k4.32m31.00--1.97--0.6293-0.0381-0.03810.58350.18631.641.967.84221,520.00-10.69-1.07-14.05-1.4650.5452.27-6.52-0.6131.08-6.220.1123---4.17-3.44-393.90--12.89--
Venus Concept Inc76.35m-37.25m4.34m304.00------0.0569-6.86-6.8614.05-2.540.69721.032.30251,164.50-33.83-32.71-50.39-44.0168.3268.16-48.52-48.501.39-3.931.22---23.2628.3114.76---35.08--
Arch Therapeutics Inc115.33k-7.86m4.39m8.00------38.04-4.07-4.070.0509-2.020.06520.0613--14,416.25-444.57-188.28---804.6327.04---6,819.08-26,945.920.042-2.02----383.83---32.35---21.76--
Pressure Biosciences Inc2.27m-29.56m4.80m15.00------2.11-1.70-1.700.1299-1.221.022.289.17151,505.30-1,074.63-643.54----6.8934.75-1,050.30-798.210.0185-0.4182-----13.64-5.0521.52---34.47--
BIOLASE Inc49.16m-37.62m4.83m157.00------0.0982-37.97-37.9738.540.57261.342.388.68313,146.50-56.30-49.28-115.21-85.8034.0235.27-41.97-50.720.683-6.610.8778--1.451.27-30.39--18.63--
ADM Tronics Unlimited Inc2.85m-716.86k5.55m7.00--5.03--1.95-0.0106-0.01060.04210.01630.97723.854.25---24.62-11.45-38.81-15.7738.4543.73-25.19-15.281.24--0.2902--14.66-0.415993.04------
Guided Therapeutics Inc98.00k-3.76m5.56m4.00------56.75-0.074-0.0740.0019-0.07030.03890.105115.0824,500.00-138.59-136.13----36.7329.39-3,560.20-3,666.670.1582-12.94----653.8511.4524.40------
Heart Test Laboratories Inc18.60k-6.39m5.82m12.00--0.6543--313.00-0.4912-0.49120.00090.13570.00260.0092.531,550.00-89.51---120.71--67.31---34,362.42--4.70-16.410.0547---64.16---31.61------
Data as of Apr 29 2024. Currency figures normalised to Encision Inc's reporting currency: US Dollar USD

Institutional shareholders

8.20%Per cent of shares held by top holders
HolderShares% Held
DAFNA Capital Management LLCas of 31 Dec 2023964.66k8.20%
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.